We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Strategies for Management of Anemia During Triple Combination Therapy.
- Authors
Kwo, Paul Y.
- Abstract
The article discusses the strategies that guided anemia management during a triple combination therapy consisting of ribavirin (RBV). A study suggested that reducing RBV dose can be beneficial for patients who developed anemia while on RBV/pegIFN-α therapy. The efficacy of the addition of boceprevir and telaprevir is noted. Another strategy that can be used by clinicians is using erythropoietin to boost hemoglobin levels.
- Subjects
ANEMIA prevention; THERAPEUTIC use of interferons; PUBLIC health surveillance; ANEMIA; COMBINATION drug therapy; ERYTHROPOIETIN; HEPATITIS C; RIBAVIRIN; TIME
- Publication
Gastroenterology & Hepatology, 2012, Vol 8, Issue 9, p6
- ISSN
1554-7914
- Publication type
Article